Top news of the week: 26.05.2021.
Startups
Column: California’s stem cell program found a disease cure, but it’s being blocked by a biotech firm
A biotech firm has halted work on a state-funded disease cure, purely for its bottom line.
Organizer of 2021 CAPCaT Big Company/Little Company Showcase
See 8 breakthrough point-of-care innovations and learn about strategic partnership and grant opportunities that can accelerate YOUR startup.
Miami Just Rolled Out Its Newest Red Carpet To The Tech World. Are San Francisco And Austin Paying Attention?
Miami and its newly minted 'Time 100' Mayor Francis Suarez are showing no signs of slowing down their charm offensive to make 'Silicon Beach' the next technology and innovation capital of ...
This Cloud Startup Raised $50 Million To Help Biopharma Companies Automate Quality Control
San Francisco-based Qualio is modernizing a niche area thrust into the spotlight by production issues with Covid-19 vaccines.
New JV from upstart biotechs Pyxis, Alloy aims for rapid drug development in cancer, autoimmune diseases
Kyma Therapeutics from Alloy Therapeutics and Pyxis Oncology will work on immune-modulating targets selected in cancer and autoimmune diseases. The candidates will be developed to what ...
Bon voyage: Voyager Therapeutics’ CEO, R&D chief exit as beleaguered biotech looks to the future
Battered and bruised by a tough journey, the Voyager 1 space probe is exiting our Solar System into worlds unknown; now, those running its earthly biotech namesake are taking a similar same ...
Spanish VC Ysios bags €216M to build EU-skewed biotech portfolio
Ysios Capital has closed its third fund at €216 million ($265 million). The fund, the largest raised by Ysios to date, equips the Spanish VC shop to invest in up to 15 companies in Europe ...
MassBio® Welcomes Two Members to its Board of Directors
The Massachusetts Biotechnology Council (MassBio®) today announced the appointment of two life sciences executives to the organization’s Board of Directors.